Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients

Clinical Trial ID NCT02565082

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02565082

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sickle-cell disease. Lancet 2010 5.64
2 Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003 4.44
3 Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003 1.96
4 Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007 1.65
5 Thrombosis and sickle cell disease. Semin Thromb Hemost 2011 1.32
6 Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children. Am J Hematol 2011 0.84
7 Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management. Med Trop (Mars) 2010 0.80
8 Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays. Thromb Res 2011 0.78
Next 100